Lurasidone hydrochloride is an atypical antipsychotic agent belonging to the benzisothiazole class, primarily indicated for the treatment of schizophrenia and depressive episodes associated with bipolar… Read more
![Chemical structure of ((1R,2R)-2-(((3aR,4R,7S,7aS)-1,3-Dioxooctahydro-2H-4,7-methanoisoindol-2-yl)methyl)cyclohexyl)methyl 4-(benzo[d]isothiazol-3-yl)piperazine-1-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1807983-62-5-1R2R-2-3aR4R7S7aS-13-Dioxooctahydro-2H-47-methanoisoindol-2-ylmethylcyclohexylmethyl-4-benzodisothiazol-3-ylpiperazine-1-carboxylate.png&w=3840&q=75)
![Chemical structure of ((1R,2R)-2-((4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methanamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1260138-03-1-1R2R-2-4-Benzodisothiazol-3-ylpiperazin-1-ylmethylcyclohexylmethanamine.png&w=3840&q=75)
![Chemical structure of ((1R,2R)-2-((4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl 4-(benzo[d]isothiazol-3-yl)piperazine-1-carboxylate hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R2R-2-4-Benzodisothiazol-3-ylpiperazin-1-ylmethylcyclohexylmethyl-4-benzodisothiazol-3-ylpiperazine-1-carboxylate-hydrochloride.png&w=3840&q=75)
Lurasidone hydrochloride is an atypical antipsychotic agent belonging to the benzisothiazole class, primarily indicated for the treatment of schizophrenia and depressive episodes associated with bipolar I disorder. Its mechanism of action involves functioning as an antagonist at dopamine D2 and serotonin 5-HT2A receptors. In pharmaceutical research and development, high-quality reference standards are essential for characterizing this active ingredient and its related substances. This category includes comprehensive materials for impurity profiling, allowing laboratories to monitor synthesis by-products and degradation species during quality control. Furthermore, stable isotope labelled compounds are available to provide internal standards for sensitive bioanalytical methods, such as liquid chromatography-mass spectrometry. By utilizing these characterized reference standards, laboratories can ensure robust method validation, maintain compliance with regulatory requirements for impurity identification, and support the overall assessment of drug purity and potency throughout the manufacturing and stability testing lifecycles.